Novo Nordisk A/S (NVO)
46.50
+0.74
(+1.62%)
USD |
NYSE |
May 07, 10:43
Novo Nordisk Free Cash Flow : 4.403B for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Evaxion AS | -- |
| Ascendis Pharma A/S | 52.82M |
| Prothena Corp. Plc | -168.85M |
| Viking Therapeutics, Inc. | -340.33M |
| Cellectis SA | -43.68M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 1.243B |
| Cash from Investing (Quarterly) | -6.527B |
| Cash from Financing (Quarterly) | 4.428B |
| Free Cash Flow Per Share (Quarterly) | -1.224 |
| Free Cash Flow to Equity (Quarterly) | -10.11B |
| Free Cash Flow to Firm (Quarterly) | -5.447B |
| Free Cash Flow Yield | 2.13% |